Expression of β-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen: Correlation with sensitivity to microtubule active agents

Clinical Cancer Research

Volumn 7, Issue 9, 2001, Pages 2912-2922

  Nicoletti, Maria I ^a,b   Valoti, Giorgio ^a   Giannakakou, Paraskevi ^b   Zhan, Zhirong ^b   Kim, Jon Hyeok ^c   Lucchini, Valeria ^d   Landoni, Fabio ^d   Mayo, Joseph G ^e   Giavazzi, Raffaella ^a   Fojo, Tito ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c University of Ulsan   (South Korea)

^d SAN GERARDO HOSPITAL   (Italy)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA TUBULIN; PACLITAXEL;

ANIMAL EXPERIMENT; ARTICLE; CORRELATION FUNCTION; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; MICROTUBULE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; MALE; MICE; MICE, NUDE; MICROTUBULES; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PACLITAXEL; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TUBULIN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034807154     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Paclitaxel in metastatic breast cancer: A trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines
2. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer
3. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
4. Taxol in ovarian cancer
5. Taxol: Mechanisms of action and resistance
6. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in α-and β-tubulin
7. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization
8. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes
9. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified β-tubulin isotypes
10. Altered expression of Mβ2, the class II β-tubulin isotype, in a murine J774.2 cell line with a high level of Taxol resistance
11. Altered β-tubulin isotype expression in paclitaxel-resistant prostate carcinoma cells
12. Novel mechanism of resistance to paclitaxel (Taxol®) in human K562 leukemia cells by combined selection with PSC833
13. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of interleukin (IL) 6. IL-8, and monocyte chemotactic protein 1 in the paclitaxe1-resistant phenotype
14. Multiple forms of tubulin: Different gene products and covalent modifications
15. Identification of conserved isotype-defining variable region sequences for four vertebrate β tubulin polypeptide classes
16. Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy
17. Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease
18. Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts
19. Molecular characterisation of a panel of human ovarian carcinoma xenografts
20. Phase II preclinical drug screening in human tumor xenografts: A first European multicenter collaborative study
21. Antitumor activity of Taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice
22. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts
23. Cellular genes analogous to retroviral oncogenes are transcribed in human tumour cells
24. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
25. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression
26. Three expressed sequences within the human β-tubulin multigene family each define a distinct isotype
27. High-performance liquid chromatographic assay for the determination of the novel taxane derivative IDN5109 in mouse plasma
28. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Drug Screen
29. Paclitaxel resistance in non-small-cell lung cancer associated with β-tubulin gene mutations
30. Properties of cancer cells in immunodepressed animals
31. Increase of βIII- and βIVa-tubulin isotypes in human prostate carcinoma cells as a result of estramustine resistance
32. Microtubule dynamics in vitro are regulated by the tubulin isotype composition
33. Removal of βIII isotype enhances Taxol-induced microtubule assembly